Dacryocystitis
dacryocystitis

Key sign: Swelling in dacryocystitis is always below the medial canthal tendon. A mass above the tendon suggests a lacrimal sac tumor (rare) - Wills Eye Manual
| Condition | Distinguishing Feature |
|---|---|
| Preseptal/facial cellulitis | No punctal discharge on pressure; patent lacrimal system on irrigation |
| Dacryocystocele | Non-inflamed, present at birth; in infants |
| Acute ethmoid sinusitis | Tenderness over nasal bone medial to inner canthus; imaging diagnostic |
| Frontal sinus mucocele | Swelling above medial canthal tendon; proptosis; downward globe displacement |
| Lacrimal sac tumor | Mass above medial canthal tendon; no discharge |
Do NOT attempt to probe or irrigate the lacrimal system during acute infection - Kanski's & Wills Eye Manual
| Severity | Regimen |
|---|---|
| Mild, afebrile, systemically well | Cephalexin 500 mg PO q6h or Amoxicillin/clavulanate 875/125 mg PO b.i.d. |
| Suspected MRSA | TMP-SMX DS (160/800 mg) PO q12h or Clindamycin 300 mg PO t.i.d. |
| Febrile, acutely ill | Hospitalize; Cefazolin 1 g IV q8h |
| Severity | Regimen |
|---|---|
| Mild, afebrile | Amoxicillin/clavulanate 25-45 mg/kg/d PO in 2 divided doses (max 90 mg/kg/d) |
| Moderate-severe / febrile | Hospitalize; Cefuroxime 50-100 mg/kg/d IV in 3 divided doses |
| Suspected MRSA | Vancomycin 10-13 mg/kg IV q6-8h |
Indications and complications of endonasal dcr
endonasal endoscopic dacryocystorhinostomy indications complications
| Indication | Notes |
|---|---|
| Primary acquired nasolacrimal duct obstruction (PANDO) | Most common indication; anatomic obstruction at the sac-duct junction |
| Chronic dacryocystitis | Recurrent or persistent lacrimal sac infection with NLD obstruction |
| Mucocele / pyocele of the lacrimal sac | Chronic obstruction causing sac distension with mucus or pus |
| Dacryolithiasis | Middle-aged patients with lacrimal duct stones |
| Functional NLD obstruction | Critical narrowings causing delayed lacrimal flow; good patency rates but symptom relief less predictable (~81%) |
| Failed prior external DCR | Endoscopic revision avoids scarred external tissue; revision outcomes: 91.3% anatomic patency, 87% functional success |
| Congenital NLD obstruction | When probing has failed or bony atresia/complex anomalies of upper NLD are present |
| Cosmetically sensitive patients | Avoids the external skin scar of open DCR |
| Bleeding diathesis / anticoagulation | Endonasal approach gives better intraoperative visualization and hemostasis than external; preferred by some surgeons in anticoagulated patients |
| Simultaneous nasal pathology requiring surgery | Additional nasal procedures (septoplasty, turbinoplasty) can be done at the same time (needed in ~50% of endonasal DCRs) |
| Complication | Comment |
|---|---|
| CSF leak | Due to inadvertent skull base penetration; requires immediate recognition and repair |
| Orbital penetration / EOM injury | Erroneous dissection into the orbit |
| Postoperative frontal/maxillary sinusitis | Damage to sinus drainage pathways; almost exclusively reported in series not involving otolaryngologists |
| CPAP-related air regurgitation | 80% of post-DCR patients on CPAP experience ophthalmic symptoms; half subsequently stop using CPAP |
| Technique | Immediate Success | ~5-Year Success |
|---|---|---|
| Endoscopic DCR | 84-94% | 92% |
| External DCR | 65-100% | 94% |
| Laser-assisted DCR | 47-100% | 38% (poor long-term) |
"Failures in endoscopic DCR are primarily due to inadequate marsupialization of the lacrimal sac mucosa." - Cummings Otolaryngology
"Endonasal DCR has the advantage of creating no external incision, having similar outcomes to external DCR, and being an ideal option for revision cases." - Cummings Otolaryngology